<p>Skin Gb3 load is higher in male and female FD patients with classical phenotype compared to respective healthy controls. Patients with non-classical phenotype do not differ from controls and only one patient out of seven exceeded the threshold of >0.05% ROI Gb3 deposition in distal skin. Number of subjects from left to right: n = 32, n = 2, n = 5, n = 39, n = 5, n = 10, n = 11. Abbreviations: Co = controls; F = female; Gb3 = globotriaosylceramide 3; M = male; ROI: investigated region of interest on skin punch biopsy specimens; SFN = small fiber neuropathy. *p<0.05, **p<0.01.</p
BACKGROUND: Fabry Disease (FD) is characterized by globotriaosylceramide-3 (Gb3) accumulation in se...
International audienceBackgroud: Fabry disease (OMIM #301 500), the most prevalent lysosomal storage...
Background: Screening for Fabry disease (FD) in high risk populations yields a significant number of...
Background The X-chromosomally linked life-limiting Fabry disease (FD) is associated with deposits ...
The X-chromosomally linked life-limiting Fabry disease (FD) is associated with deposits of the sphin...
<p>The horizontal mark indicated the median. It is noteworthy that lyso-Gb3 levels in males are ∼10 ...
BACKGROUND: Fabry Disease (FD) is characterized by globotriaosylceramide-3 (Gb3) accumulation in sev...
Fabry disease leads to renal, cardiac, and cerebrovascular manifestations. Phenotypic differences be...
<p>Illustration of the outcome of investigations to confirm the diagnosis of Fabry disease. α-Gal A:...
<p>Correlation analyses: (1) Plasma globotriaosylsphingosine (Lyso-Gb3) and plasma α-Gal A activity ...
<p>P: Pain in peripheral extremities, A: Angiokeratomas, HH: Hypohidrosis, CO: Corneal opacities, RD...
Fabry disease (FD), a lysosomal storage disorder caused by α-galactosidase A (GLA) gene variants, ha...
<p>(A) Age at diagnosis for males <i>N215S</i> (n = 37), males <i>non-N215S</i> (n = 58) and females...
<p>Correlation analyses: Life time exposure to Lyso-Gb3 ([Lyso-Gb3]*age) and: clinical severity, (MS...
Fabry disease' (FD) phenotype is heterogeneous: alpha-galactosidase A gene mutations (GLA) can lead ...
BACKGROUND: Fabry Disease (FD) is characterized by globotriaosylceramide-3 (Gb3) accumulation in se...
International audienceBackgroud: Fabry disease (OMIM #301 500), the most prevalent lysosomal storage...
Background: Screening for Fabry disease (FD) in high risk populations yields a significant number of...
Background The X-chromosomally linked life-limiting Fabry disease (FD) is associated with deposits ...
The X-chromosomally linked life-limiting Fabry disease (FD) is associated with deposits of the sphin...
<p>The horizontal mark indicated the median. It is noteworthy that lyso-Gb3 levels in males are ∼10 ...
BACKGROUND: Fabry Disease (FD) is characterized by globotriaosylceramide-3 (Gb3) accumulation in sev...
Fabry disease leads to renal, cardiac, and cerebrovascular manifestations. Phenotypic differences be...
<p>Illustration of the outcome of investigations to confirm the diagnosis of Fabry disease. α-Gal A:...
<p>Correlation analyses: (1) Plasma globotriaosylsphingosine (Lyso-Gb3) and plasma α-Gal A activity ...
<p>P: Pain in peripheral extremities, A: Angiokeratomas, HH: Hypohidrosis, CO: Corneal opacities, RD...
Fabry disease (FD), a lysosomal storage disorder caused by α-galactosidase A (GLA) gene variants, ha...
<p>(A) Age at diagnosis for males <i>N215S</i> (n = 37), males <i>non-N215S</i> (n = 58) and females...
<p>Correlation analyses: Life time exposure to Lyso-Gb3 ([Lyso-Gb3]*age) and: clinical severity, (MS...
Fabry disease' (FD) phenotype is heterogeneous: alpha-galactosidase A gene mutations (GLA) can lead ...
BACKGROUND: Fabry Disease (FD) is characterized by globotriaosylceramide-3 (Gb3) accumulation in se...
International audienceBackgroud: Fabry disease (OMIM #301 500), the most prevalent lysosomal storage...
Background: Screening for Fabry disease (FD) in high risk populations yields a significant number of...